13F filing recap · Q1 2024

What did Miller Value Partners buy in Q1 2024?

Reported stock-position changes between this filing and the previous one.

Stock value

$145.02M

Positions

Estimated turnover

53.2%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

LNCLincoln National Corp$6.35Mreported value+199.0K shares CHRDChord Energy Corp$6.18Mreported value+34.7K shares UGIUgi Corporation$4.10Mreported value+167.0K shares BMYBristol-Myers Squibb Company$3.25Mreported value+60.0K shares CLFCleveland-Cliffs Inc.$209.2Kreported value+9.2K shares

Increased positions

TAT&T Inc.$10.35Mreported value+36.0K shares+6.5%CTOCto Realty Growth, Inc.$7.52Mreported value+15.0K shares+3.5%BCCBoise Cascade Company$6.13Mreported value+35.0K shares+700.0%NBRNabors Industries Ltd$6.01Mreported value+4.2K shares

Reduced positions

STLAStellantis N.v.$12.17Mreported value-66.0K shares-13.3%JXNJackson Financial Inc.$10.09Mreported value-47.1K shares-23.6%BFHBread Financial Holdings, Inc.$9.49Mreported value-53.1K shares-17.2%WALWestern Alliance Bancorporation$9.26Mreported value-30.3K shares

Exited positions

UPROProshares Trust$10.23Mprior reported value-186.9K shares-100.0%MPTMedical Properties Trust Inc$4.87Mprior reported value-991.0K shares-100.0%HRBH&R Block, Inc.$3.05Mprior reported value-63.0K shares-100.0%MEDMedifast, Inc.$2.83Mprior reported value-42.1K shares